Site Logo   Help
TMHP
NDC
Advanced SearchExecute search
Current Location
Home
NDC
Reminder to Include NDC Number on Palivizumab (Synagis) Claim Forms
Information posted October 24, 2008: The respiratory syncytial virus (RSV) season is quickly approaching, and providers are reminded that they must include the complete 11-digit National Drug Code (NDC) number when submitting claims for the administration of the palivizumab (Synagis) vaccine using procedure code 90378. If the NDC information is missing, claims submitted with procedure code 90378 will be denied even when they have been prior authorized. Click on the title to view details.

Two NDC codes currently associated with procedure code 90378 are listed below:

·         Drug Name - Palivizumab (Synagis) 100MG/1ML Vial NDC – 60574411301

·         Drug Name - Palivizumab (Synagis) 50MG/0.5ML Vial NDC – 60574411401

Providers can access specific instructions for entering the NDC on the UB-04 CMS-1450, CMS-1500, and Family Planning 2017 claim forms by viewing the NDC web page. This information was also published in the May/June 2008 Texas Medicaid Bulletin, No. 215 and the May 2008 CSHCN Services Program Provider Bulletin, No. 66.

For more information, call the TMHP Contact Center at 1-800-925-9126 or the TMHP-CSHCN Services Program Contact Center at 1-800-568-2413.

Terms and Conditions|Contact Us|Help|Site Map